Lundbeck CEO Resigns In Ethics Breach Over Outside Shares
The CEO of Danish pharmaceutical company H. Lundbeck A/S resigned on Monday after revealing he accepted shares of a biotech firm without getting board approval, a breach that was aggravated when...To view the full article, register now.
Already a subscriber? Click here to view full article